Ocugen RPDD Stargardt
May 28, 2025

FDA Grants Rare Pediatric Disease Designation to Ocugen’s Gene Therapy for Stargardt Disease

Ocugen’s OCU410ST gene therapy lands a rare badge of honor in the fight against IRDs. The U.S. Food and Drug…

Viridian_long term_durability_data_TED_2_copy
May 22, 2025

Viridian Shares New 52-Week Phase III Trial Data for Active TED

New THRIVE trial data highlight long-term proptosis response with veligrotug in thyroid eye disease patients. Fresh long-term data is showing…

Discover our fascinating content at issuu

explore